SanBio Co (TSE:4592) Total Tax Payable : 円18.51 Mil (As of Jan. 2024)

View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Total Tax Payable?

SanBio Co's Total Tax Payable for the quarter that ended in Jan. 2024 was 円18.51 Mil.

SanBio Co's quarterly Total Tax Payable increased from Jul. 2023 (円0.61 Mil) to Oct. 2023 (円0.91 Mil) and increased from Oct. 2023 (円0.91 Mil) to Jan. 2024 (円18.51 Mil).

SanBio Co's annual Total Tax Payable declined from Jan. 2022 (円122.49 Mil) to Jan. 2023 (円0.61 Mil) but then increased from Jan. 2023 (円0.61 Mil) to Jan. 2024 (円18.51 Mil).

SanBio Co Total Tax Payable Historical Data

The historical data trend for SanBio Co's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Total Tax Payable Chart

SanBio Co Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Total Tax Payable

Get a 7-Day Free Trial

30.86

202.69

122.49

0.61

18.51

SanBio Co Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Tax Payable	Get a 7-Day Free Trial															0.61	0.30	0.61	0.91	18.51

SanBio Co Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

SanBio Co Total Tax Payable Related Terms

Thank you for viewing the detailed overview of SanBio Co's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

SanBio Co (TSE:4592) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

SNBIF:USA

Address

8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044

Website

https://www.sanbio.com

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines